Table 1 Baseline demographics of the study population
Variables | Anti- T. gondii antibody IgG | t/χ2 | p value | |
|---|---|---|---|---|
Negative | Positive | |||
(n = 6945) | (n = 2520) | |||
Age(years)a | 42.48 ± 15.76 | 49.41 ± 16.37 | −18.71 | < 0.001 |
Age groups (%) | ||||
< 30 years | 1982 (28.54%) | 460(18.25%) | 345.87 | < 0.001 |
30–40 years | 1623(23.37%) | 391(15.52%) | ||
40–50 years | 1165(16.77%) | 380(15.08%) | ||
50–60 years | 839(12.08%) | 422(16.75%) | ||
60–70 years | 985(14.18%) | 632(25.08%) | ||
≥70 years | 351(5.05%) | 235(9.33%) | ||
Gender (%) | ||||
Male | 3189(45.92%) | 1252(49.68%) | 10.52 | 0.001 |
Female | 3756(54.08%) | 1268(50.32%) | ||
Ethnicity (%) | 43.56 | < 0.001 | ||
Non-Hispanic white | 2375(34.20%) | 907(35.99%) | ||
Non-Hispanic black | 2042(29.40%) | 696(27.62%) | ||
Mexican American | 2293(33.02%) | 761(30.20%) | ||
Others | 235(3.38%) | 156(6.19%) | ||
BMI(kg/m2) | 27.47 ± 6.00 | 27.96 ± 5.85 | −3.48 | < 0.001 |
NAFLD (%) | ||||
Yes | 1625(23.40%) | 683(72.90%) | 13.77 | < 0.001 |
No | 5320(76.60%) | 1837(27.10%) | ||
Cholesterol (mmol/L)a | 5.38 ± 1.17 | 5.62 ± 1.20 | − 8.53 | < 0.001 |
Triglyceride (mmol/L)a | 1.64 ± 1.33 | 1.81 ± 1.42 | − 5.27 | < 0.001 |
FBG (mmol/L)a | 5.47 ± 2.09 | 5.80 ± 2.52 | −6.54 | < 0.001 |
Uric acid (mmol/L)a | 311.40 ± 92.37 | 322.18 ± 95.15 | − 4.98 | < 0.001 |
HbA1c (%)a | 5.54 ± 1.15 | 5.73 ± 1.27 | − 6.95 | < 0.001 |
TBIL (mmol/L)a | 9.92 ± 5.55 | 9.67 ± 5.00 | 2.01 | 0.044 |
ALT (U/L)a | 18.32 ± 15.36 | 17.96 ± 17.44 | 0.96 | 0.34 |
AST (U/L)a | 21.73 ± 14.09 | 21.97 ± 14.18 | −0.72 | 0.47 |
GGT (U/L)a | 25.72 ± 39.28 | 28.45 ± 53.48 | − 2.69 | 0.007 |
ALP (U/L)a | 86.24 ± 27.85 | 91.41 ± 38.98 | − 7.08 | < 0.001 |
Albumin (g/L)a | 41.52 ± 3.87 | 41.16 ± 3.84 | 4.03 | < 0.001 |
Globulin (g/L)a | 33.14 ± 4.62 | 33.72 ± 4.82 | − 4.69 | < 0.001 |
Creatinine (umol/L)a | 93.27 ± 26.13 | 96.35 ± 32.40 | − 4.71 | < 0.001 |